Compare Aurobindo Pharma with Biocon - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA BIOCON AUROBINDO PHARMA/
BIOCON
 
P/E (TTM) x 9.9 50.2 19.7% View Chart
P/BV x 3.2 6.2 51.3% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AUROBINDO PHARMA   BIOCON
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-20
BIOCON
Mar-21
AUROBINDO PHARMA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs838488 171.8%   
Low Rs281275 102.4%   
Sales per share (Unadj.) Rs394.259.2 665.7%  
Earnings per share (Unadj.) Rs48.57.7 629.6%  
Cash flow per share (Unadj.) Rs65.013.7 475.8%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs286.962.3 460.7%  
Shares outstanding (eoy) m585.931,200.00 48.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.46.4 22.1%   
Avg P/E ratio x11.549.4 23.3%  
P/CF ratio (eoy) x8.627.9 30.9%  
Price / Book Value ratio x2.06.1 31.9%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m327,872457,350 71.7%   
No. of employees `000NANA-   
Total wages/salary Rs m32,19217,410 184.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m230,98571,058 325.1%  
Other income Rs m1,9196,052 31.7%   
Total revenues Rs m232,90477,110 302.0%   
Gross profit Rs m48,38213,145 368.1%  
Depreciation Rs m9,6677,151 135.2%   
Interest Rs m3,051577 528.8%   
Profit before tax Rs m37,58211,469 327.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,1352,215 412.4%   
Profit after tax Rs m28,4479,254 307.4%  
Gross profit margin %20.918.5 113.2%  
Effective tax rate %24.319.3 125.9%   
Net profit margin %12.313.0 94.6%  
BALANCE SHEET DATA
Current assets Rs m164,12576,004 215.9%   
Current liabilities Rs m113,86842,101 270.5%   
Net working cap to sales %21.847.7 45.6%  
Current ratio x1.41.8 79.8%  
Inventory Days Days15137 11.2%  
Debtors Days Days6863 109.0%  
Net fixed assets Rs m123,507106,142 116.4%   
Share capital Rs m5866,000 9.8%   
"Free" reserves Rs m167,51868,728 243.7%   
Net worth Rs m168,10474,728 225.0%   
Long term debt Rs m029,616 0.0%   
Total assets Rs m287,632182,146 157.9%  
Interest coverage x13.320.9 63.8%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.4 205.9%   
Return on assets %11.05.4 202.9%  
Return on equity %16.912.4 136.7%  
Return on capital %24.211.5 209.4%  
Exports to sales %46.40-   
Imports to sales %15.17.2 211.2%   
Exports (fob) Rs m107,126NA-   
Imports (cif) Rs m34,9025,084 686.5%   
Fx inflow Rs m107,44511,791 911.2%   
Fx outflow Rs m38,9915,084 766.9%   
Net fx Rs m68,4546,707 1,020.6%   
CASH FLOW
From Operations Rs m43,81311,597 377.8%  
From Investments Rs m-15,676-36,247 43.2%  
From Financial Activity Rs m-19,47225,640 -75.9%  
Net Cashflow Rs m8,712723 1,205.0%  

Share Holding

Indian Promoters % 48.8 39.7 122.7%  
Foreign collaborators % 3.1 20.9 14.7%  
Indian inst/Mut Fund % 38.4 23.4 163.7%  
FIIs % 23.7 15.9 149.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 39.4 122.4%  
Shareholders   243,315 338,827 71.8%  
Pledged promoter(s) holding % 22.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SAKAR HEALTHCARE   PARNAX LAB  JUBILANT PHARMOVA   SUN PHARMA  ORTIN LABS   



Today's Market

Sensex Ends 123 Points Higher; Bharti Airtel and Eicher Motors Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

BIOCON Announces Quarterly Results (1QFY22); Net Profit Down 4.0% (Quarterly Result Update)

Jul 26, 2021 | Updated on Jul 26, 2021

For the quarter ended June 2021, BIOCON has posted a net profit of Rs 2 bn (down 4.0% YoY). Sales on the other hand came in at Rs 18 bn (up 3.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (4QFY21); Net Profit Up 118.6% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, BIOCON has posted a net profit of Rs 4 bn (up 118.6% YoY). Sales on the other hand came in at Rs 18 bn (up 16.3% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

These Stocks Are Ready to Zoom(Fast Profits Daily)

Aug 3, 2021

These stocks are the best from a traders point of view.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

Devyani International IPO: Key Points to Consider(Views On News)

Jul 31, 2021

Its raining IPOs as 4 public issues open next week on the same day. Which one will you subscribe to?

A Rare Opportunity for Long-Term Investors Amid the Rout in China's Tech Stocks(Profit Hunter)

Jul 29, 2021

The epicentre of a tech-bubble led market crash in 2021 is closer than you think.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Aug 5, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS